Abstract
Abstract
Background
Bronchiectasis may be associated and/or co-exist with respiratory diseases as bronchial asthma and chronic obstructive pulmonary disease (COPD) or non-respiratory diseases. However, data about this association and/or co-existence is little. The objectives of the study were to determine the prevalence of bronchiectasis among admitted patients in the Chest Department in 10 years’ period (2008–2018) and to detect associated and/or co-existent respiratory diseases. In a retrospective cohort study, the diagnosis of bronchiectasis was based on chest HRCT. Data included the total number of hospitalized patients during this period, their final diagnosis, co-existing diagnosis associated with bronchiectasis, and sonographic and spirometric findings.
Results
The total number of patients admitted in 2008–2018 was 17,531 patients. The prevalence of bronchiectasis during this period was 9.04%. COPD was the commonest suspected cause (54.1%) followed by post-tuberculosis bronchiectasis (17.1%). On admission, 63.7% had acute type 2 respiratory failure, 21.1% had decompensated cor pulmonale, 3.8% required mechanical ventilation (MV), and 1.3% required non-invasive MV. On discharge, 9.9% required long-term oxygen therapy. The presence of B lines in chest ultrasonography was recorded in 68.2% and air bronchogram in 29.1%.
Conclusions
The prevalence of bronchiectasis among admitted patients was still increasing. COPD with bronchiectasis accounted for more than half of cases. More researches are needed to identify the impact of the COPD-bronchiectasis phenotype.
Trial registration
ClinicalTrials.gov, NCT04101448
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Laennec RA (1834) Treatise in the diseases of the chest and on mediate auscultation, 4th edn. Longman, London
2. Cole PJ. Inflammation: a two-edged sword - the model of bronchiectasis. Eur. J. Respir. Dis. Suppl. 1986; 147: 6–15. 6.
3. Seitz AE, Olivier KN, Adjemian J (2012) Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007. Chest 142:432–439
4. Ringshausen FC, de Roux A, Pletz M (2013) Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One 8:e71109
5. Quint JK, , Millett ERC, Joshi M, Navaratnam V, et al., Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004-2013: a population based cohort study. Eur Respir J 2016; 47(1): 186–193.